CNS Pharmaceuticals, Inc.
CNSP
Last
$5.23
Day
+0.2%
1y
-46.8%
5y
-100.0%
52w
-49.3%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1333d
EMA 21
5.34
EMA 50
5.34
EMA 200
94.12
20d high
-6.1%
5y high
-100.0%
5y range
0th
Positions held
Your positionsCNSP isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-3
Hold
watch
Signal
Neutral
Target
$5.70
Stop
$5.05
Stop distance
3.4%
Target vs last
+9.0%
Fundamentals
| Market cap | $7.82M | Enterprise value | -$12.17M | Trailing P/E | — | Forward P/E | -13.72 |
| PEG | — | Price / book | 0.43 | Beta | 1.02 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -106.6% | ROA | -58.0% | Debt / equity | — |
| Current ratio | 5.87 | Free cash flow | -$7.94M | Analyst recommendation | none | Mean target | $10.00 |
| 52w high | $10.54 | 52w low | $1.90 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$2.6M | -$4.9M | -$6.0M | -$3.2M | -$2.4M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.7M | -$5.0M | -$6.0M | -$3.3M | -$2.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$15.9M | -$14.9M | -$18.9M | -$15.3M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$16.0M | -$14.9M | -$18.9M | -$15.3M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsCNSP · daily+2.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin